For the Inventor, By the Inventor

Enter assignee name

Pharmaleads

USPTO Granted Patents = 12

CIPO Patents = 2

EPO Patents = 9

Trademarks = 2

Forward Citations = 51

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Marie-Claude Fournie-Zaluski (7 out of 20 patents)

Bernard P Roques (7 out of 27 patents)

Hervé Poras (6 out of 7 patents)

4. Michel Wurm (3 out of 4 patents)

5. Stéphane Melik Parsadaniantz (2 out of 2 patents)

6. Annabelle Reaux-Le Goazigo (2 out of 2 patents)

7. Hervé Poras (2 out of 4 patents)

8. Jean-Baptiste Michel (1 out of 3 patents)

9. Loic Lefebvre (1 out of 1 patent)

10. Xinjun Zhao (1 out of 4 patents)

11. Luca Gamberoni (1 out of 1 patent)

12. Sabrina De Rosa (1 out of 1 patent)

13. Rosario Velardi (1 out of 2 patents)

14. François Rouzet (1 out of 2 patents)

15. Dominique Leguludec (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 11648231 - Amino acid derivatives containing a disulfanyl group in the form of an NEP and APN inhibitor for the prevention and treatment of trigeminal nerve pain (2023-05-16),

2. 11090317 - Aminophosphinic derivatives for preventing and treating eye inflammation (2021-08-17),

3. 10688113 - Methods of treating eye pain with aminophosphinic derivatives (2020-06-23),

4. 10399936 - Industrial process for the preparation of (5S, 10S)-10-benzyl-16-methyl-11, 14, 18-trioxo-15, 17, 19-trioxa-2,7,8-trithia-12-azahenicosan-5-aminium(E)-3-carboxyacrylate salt (2019-09-03),

5. 10131681 - Aminophosphinic derivatives that can be used in the treatment of pain (2018-11-20),

6. 9388129 - Mixed inhibitors of aminopeptidase N and neprilysin (2016-07-12),

7. 9272054 - Agents for the molecular imaging of serine-protease in human pathologies (2016-03-01),

8. 8703747 - Aminophosphinic derivatives that can be used in the treatment of pain (2014-04-22),

9. 8247609 - Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase N inhibitors (2012-08-21),

10. 8247608 - Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase N inhibitors (2012-08-21),

11. 7875436 - Peptide substrates recognizable by a botulinum toxin A, BoNT/A and the use thereof (2011-01-25),

12. 6324785 - Process for harvesting organic compounds from plant roots (2001-12-04),

Pharmaleads is a biotechnology company specializing in the development of innovative pain management therapies. With a focus on non-opioid alternatives, Pharmaleads is dedicated to improving patient outcomes and reducing the opioid epidemic. Through cutting-edge research and strategic partnerships, Pharmaleads is at the forefront of the pain management industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

12 Patents

#298 in Paris

#1,458 in France

#46,738 in the World

Pharmaleads

Forward Citations = 51

19 inventors:

Marie-Claude Fournie-Zaluski (7 out of 20 patents)

Bernard P Roques (7 out of 27 patents)

Hervé Poras (6 out of 7 patents)

4. Michel Wurm (3 out of 4 patents)

5. Stéphane Melik Parsadaniantz (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…